Stay updated on Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Sign up to get notified when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.

Latest updates to the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the study record content. Previously visible sponsor and study details are no longer accessible.SummaryDifference22%

- Check18 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, representing an update to the page's underlying software version.SummaryDifference0.0%

- Check25 days agoChange DetectedTel Litwinsky, Israel, 52621 was added as a participating site, replacing Qiryat Krinitzi, Israel, 52621 in the Locations section.SummaryDifference0.0%

- Check32 days agoChange DetectedQiryat Krinitzi, Israel, 52621 was added as a Novo Nordisk investigational site, replacing Tel Litwinsky, Israel, 52621. The page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This indicates a new site release, typically reflecting maintenance updates rather than substantive content changes.SummaryDifference0.0%

- Check68 days agoChange DetectedThe Revision label on the page was updated from v3.6.3 to v3.6.4. This reflects an internal site version update without changes to the study content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.